Skip to main content

Peer Review reports

From: Effects of the factor Xa inhibitor rivaroxaban on the differentiation of endothelial progenitor cells

Original Submission
14 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
19 Sep 2022 Reviewed Reviewer Report - Yuqi Cui
22 Sep 2022 Reviewed Reviewer Report
15 Mar 2023 Author responded Author comments - Masashi Sakuma
Resubmission - Version 4
15 Mar 2023 Submitted Manuscript version 4
24 Mar 2023 Author responded Author comments - Masashi Sakuma
Resubmission - Version 5
24 Mar 2023 Submitted Manuscript version 5
3 Apr 2023 Author responded Author comments - Masashi Sakuma
Resubmission - Version 6
3 Apr 2023 Submitted Manuscript version 6
8 Apr 2023 Author responded Author comments - Masashi Sakuma
Resubmission - Version 7
8 Apr 2023 Submitted Manuscript version 7
11 Apr 2023 Author responded Author comments - Masashi Sakuma
Resubmission - Version 8
11 Apr 2023 Submitted Manuscript version 8
Publishing
24 May 2023 Editorially accepted
2 Jun 2023 Article published 10.1186/s12872-023-03318-4

You can find further information about peer review here.

Back to article page